In fiscal 2012, which ended Dec 31, 2012, Tanke Biosciences Corp reported revenue of $28.6 million, up 19.8% from the year before. It recorded a net loss of $210,247. Operating income came to $4.5 million, an operating margin of 15.9%. Over the twelve months ended Sep 30, 2013, revenue was $23.0 million and the net loss was $1.6 million.
USD in millions, except per-share amounts and margins. The percent under a figure is the change from the year before.
| Line |
FY 2013
Sep 30, 2013
|
FY 2012
Dec 31, 2012
|
FY 2011
Dec 31, 2011
|
|---|---|---|---|
| Revenue |
23
-19.5%
|
29
+19.8%
|
24
|
| Cost of revenue |
16
-15.9%
|
19
+23.6%
|
15
|
| Gross profit |
7
-26.2%
|
10
+13.4%
|
9
|
| Research and development |
—
|
0
|
—
|
| Selling, general and administrative |
7
+46.5%
|
5
-24.4%
|
7
|
| Operating income |
-0
-101.1%
|
5
+160.6%
|
2
|
| Pretax income |
-1
-142.4%
|
1
+124.5%
|
-2
|
| Income tax |
0
-71.3%
|
1
+22.1%
|
1
|
| Net income |
-2
-164.1%
|
-0
+93.3%
|
-3
|
| Basic EPS |
—
|
—
|
-0.24
|
| Diluted EPS |
—
|
—
|
-0.24
|
| Weighted average shares, basic |
—
|
—
|
13
|
| Weighted average shares, diluted |
—
|
—
|
13
|
| Other measures | |||
| Depreciation and amortization |
1
+27.0%
|
1
+59.1%
|
0
|
| EBITDA |
1
-86.3%
|
5
+141.6%
|
2
|
| Interest coverage |
-0.10x
|
3.13x
|
1.28x
|
| Margins | |||
| Gross margin |
32.28%
|
34.82%
|
36.80%
|
| Operating margin |
-0.25%
|
15.87%
|
7.30%
|
| Pretax margin |
-6.26%
|
2.11%
|
-10.30%
|
| Profit margin |
-7.15%
|
-0.74%
|
-13.16%
|
| EBITDA margin |
3.50%
|
18.09%
|
8.97%
|
| Effective tax rate |
—
|
138.00%
|
—
|
How these figures are calculated
Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. The first column is the trailing twelve months through the latest quarter. More on our methodology.
New to this? Read How to Read an Income Statement, With a Real Example.
Company profile
- Industry
- Grain Mill Products (SIC 2040)
- Listed as
- TNBI (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Pearl River New City Guangzhou, China
- SEC CIK
- 1452011
- Former names
- GREYHOUND COMMISSARY, INC. (until Feb 3, 2011)
Other Grain Mill Products companies
- General Mills Inc GIS
- Ingredion Inc INGR
- Post Holdings, Inc. POST
- Freshpet, Inc. FRPT
- Forafric Global PLC AFRI
Source: SEC EDGAR filings. This is company-reported data, not investment advice.